Samsung Biologics to invest $1.5 bln to build a new factory in South Korea
South Korean drugmaker
Samsung Biologics Co Ltd plans to invest 2 trillion
won ($1.53 billion) through September 2025 to build a new
factory in South Korea, the company said in a regulatory filing
on Friday.
Samsung Biologics Co Ltd plans to invest 2 trillion
won ($1.53 billion) through September 2025 to build a new
factory in South Korea, the company said in a regulatory filing
on Friday.
($1 = 1,304.7300 won)